Registration Dossier
Registration Dossier
Please be aware that this old REACH registration data factsheet is no longer maintained; it remains frozen as of 19th May 2023.
The new ECHA CHEM database has been released by ECHA, and it now contains all REACH registration data. There are more details on the transition of ECHA's published data to ECHA CHEM here.
Use of this information is subject to copyright laws and may require the permission of the owner of the information, as described in the ECHA Legal Notice.
EC number: 307-037-4 | CAS number: 97488-98-7
Carcinogenicity
Administrative data
Description of key information
Although a long-term mammalian test of carcinogenicity has not been conducted for any of the FLL Substances, the three mutagenicity studies can also provide evidence with respect to carcinogenicity. According to the European Classification, Labelling and Packaging (CLP) Regulation: “it is recognised that genetic events are central in the overall process of cancer development. Therefore evidence of mutagenic activity in vivo may indicate that a substance has a potential for carcinogenic effects.”
Although mutagenicity has not been tested in vivo, the tests do provide consistent results indicating a general lack of a potential for in vivo mutagenicity (and by extrapolation, carcinogenicity) for the FLL Substances. A further line of evidence is that decision-tree modelling according to the Begnini-Boss Rulebase (ToxTree v.1.6) did not identify any alert for carcinogenic activity for a fish oil derivative and a vegetable oil derivative representing the FLL Substances .
Thus, it appears unlikely, based on the available information, that any of the FLL Substances could be carcinogenic and act with a non-threshold mode of action. However, the lack of in vivo data precludes a definitive classification at this time and therefore, an overall conclusion of “not classifiable” is recommended for the FLL Substances
Key value for chemical safety assessment
Justification for classification or non-classification
Although a long-term mammalian test of carcinogenicity has not been conducted for any of the FLL Substances, the three mutagenicity studies can also provide evidence with respect to carcinogenicity. According to the European Classification, Labelling and Packaging (CLP) Regulation: “it is recognised that genetic events are central in the overall process of cancer development. Therefore evidence of mutagenic activity in vivo may indicate that a substance has a potential for carcinogenic effects.”
Although mutagenicity has not been testedin vivo, the tests do provide consistent results indicating a general lack of a potential forin vivomutagenicity (and by extrapolation, carcinogenicity) for the FLL Substances. A further line of evidence is that decision-tree modelling according to the Begnini-Boss Rulebase (ToxTree v.1.6) did not identify any alert for carcinogenic activity for a fish oil derivative and a vegetable oil derivative representing the FLL Substances.
Thus, it appears unlikely, based on the available information, that any of the FLL Substances could be carcinogenic and act with a non-threshold mode of action. However, the lack of in vivo data precludes a definitive classification at this time and therefore, an overall conclusion of “not classifiable” is recommended for the FLL Substances
Additional information
Information on Registered Substances comes from registration dossiers which have been assigned a registration number. The assignment of a registration number does however not guarantee that the information in the dossier is correct or that the dossier is compliant with Regulation (EC) No 1907/2006 (the REACH Regulation). This information has not been reviewed or verified by the Agency or any other authority. The content is subject to change without prior notice.
Reproduction or further distribution of this information may be subject to copyright protection. Use of the information without obtaining the permission from the owner(s) of the respective information might violate the rights of the owner.
